NFKB1 and lung cancer: Zhao et al. [130] reported that the NF-κB signaling pathway is involved in CSE-induced EMT in HBE cells, suggesting that NF-κB activation acts as a bridge between CSE-induced chronic inflammation, EMT, and lung cancer.